Haobin Chen

1.3k total citations
21 papers, 478 citations indexed

About

Haobin Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haobin Chen has authored 21 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Haobin Chen's work include Epigenetics and DNA Methylation (5 papers), Lung Cancer Research Studies (3 papers) and Protein Degradation and Inhibitors (3 papers). Haobin Chen is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Lung Cancer Research Studies (3 papers) and Protein Degradation and Inhibitors (3 papers). Haobin Chen collaborates with scholars based in United States, China and France. Haobin Chen's co-authors include Max Costa, Hong Sun, Qin Li, Xue Zhou, Ronghe Zhang, Wei Dai, Thomas Kluz, Qing Duan, David S. Schrump and Yves Pommier and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Haobin Chen

19 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haobin Chen United States 9 297 143 94 72 57 21 478
Chenghui Ren China 7 181 0.6× 51 0.4× 56 0.6× 36 0.5× 40 0.7× 10 292
Monica D. Nye United States 15 393 1.3× 78 0.5× 176 1.9× 55 0.8× 86 1.5× 16 665
Fei Luo China 14 170 0.6× 75 0.5× 168 1.8× 35 0.5× 120 2.1× 29 576
Hengning Ke China 10 289 1.0× 100 0.7× 36 0.4× 34 0.5× 112 2.0× 17 438
Cynthia C. Jose United States 12 274 0.9× 65 0.5× 77 0.8× 16 0.2× 86 1.5× 16 448
Tiffany A. Katz United States 13 305 1.0× 90 0.6× 67 0.7× 42 0.6× 86 1.5× 21 539
Shirin Hafezi United Arab Emirates 11 164 0.6× 76 0.5× 62 0.7× 25 0.3× 81 1.4× 25 437
Nasser Pouladi Iran 13 188 0.6× 84 0.6× 34 0.4× 22 0.3× 85 1.5× 50 455
Susanne Haas Germany 14 184 0.6× 131 0.9× 21 0.2× 36 0.5× 70 1.2× 23 429
Daniel Mailo United States 9 226 0.8× 449 3.1× 50 0.5× 38 0.5× 118 2.1× 11 669

Countries citing papers authored by Haobin Chen

Since Specialization
Citations

This map shows the geographic impact of Haobin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haobin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haobin Chen more than expected).

Fields of papers citing papers by Haobin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haobin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haobin Chen. The network helps show where Haobin Chen may publish in the future.

Co-authorship network of co-authors of Haobin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Haobin Chen. A scholar is included among the top collaborators of Haobin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haobin Chen. Haobin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Yuliang, et al.. (2025). Association between waist-to-height ratio and insulin resistance in patients with polycystic ovary syndrome: a meta-analysis. Frontiers in Endocrinology. 16. 1567787–1567787. 2 indexed citations
2.
Chen, Haobin, Lei Li, Xiaoyan Liu, et al.. (2025). A glutathione-responsive L-carnitine-modified camptothecin oral nano-prodrug for cancer therapy. Journal of Molecular Structure. 1342. 142744–142744. 1 indexed citations
3.
Hong, Min, Juan Wang, Haobin Chen, et al.. (2024). Synthesis and biological evaluation of folic acid-rotenol conjugate as a potent targeted anticancer prodrug. European Journal of Pharmacology. 970. 176482–176482.
4.
Chen, Haobin, Benjamin J. Drapkin, & John D. Minna. (2024). Proteomics: A new dimension to decode small cell lung cancer. Cell. 187(1). 14–16. 1 indexed citations
5.
Liang, Changxiang, et al.. (2024). Magnesium Regulates the Migration and Differentiation of NPMSCs via the Integrin Signaling Pathway. Current Stem Cell Research & Therapy. 20(7). 768–783.
6.
Shukla, Vivek, Haitao Wang, Lyuba Varticovski, et al.. (2024). Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLC. Journal of Thoracic Oncology. 19(8). 1201–1217. 4 indexed citations
7.
Kumari, Anju, Yan-Jin Liu, V. Keith Hughitt, et al.. (2023). mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer. JCI Insight. 8(5). 15 indexed citations
8.
Chen, Haobin, Young-Kwon Park, Trudy G. Oliver, et al.. (2022). BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation. Molecular Cancer Research. 21(2). 91–101. 15 indexed citations
9.
Chen, Sheng, et al.. (2022). The effect of insulin and kruppel like factor 10 on osteoblasts in the dental implant osseointegration in diabetes mellitus patients. Bioengineered. 13(6). 14259–14269. 5 indexed citations
10.
Chen, Haobin, Renee N. Donahue, Sarthak Gupta, et al.. (2022). Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors. The Oncologist. 27(4). e353–e356. 3 indexed citations
11.
Xiong, Yin, Sichuan Xi, Sudheer Kumar Gara, et al.. (2021). Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells. JTO Clinical and Research Reports. 2(7). 100181–100181. 4 indexed citations
12.
Qu, Song, Patricia Fetsch, Anish Thomas, et al.. (2021). Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers. Journal of Thoracic Oncology. 17(1). 141–153. 86 indexed citations
13.
Xi, Sichuan, Vivek Shukla, Julie A. Hong, et al.. (2018). The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy. Annals of the American Thoracic Society. 15(Supplement_2). S124–S124. 7 indexed citations
14.
Chen, Haobin, Thomas Kluz, Ronghe Zhang, & Max Costa. (2010). Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells. Carcinogenesis. 31(12). 2136–2144. 71 indexed citations
15.
Sun, Hong, Xue Zhou, Haobin Chen, Qin Li, & Max Costa. (2009). Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicology and Applied Pharmacology. 237(3). 258–266. 112 indexed citations
16.
Li, Jingxia, Haobin Chen, Moon-shong Tang, et al.. (2009). PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. The Journal of Cell Biology. 186(2). 297–297. 19 indexed citations
17.
Sun, Hong, Xue Zhou, Haobin Chen, Qin Li, & Max Costa. (2008). Modulation of histone methylation by hexavalent chromium. Cancer Research. 68. 6–6. 3 indexed citations
18.
Duan, Qing, Haobin Chen, Max Costa, & Wei Dai. (2008). Phosphorylation of H3S10 Blocks the Access of H3K9 by Specific Antibodies and Histone Methyltransferase. Journal of Biological Chemistry. 283(48). 33585–33590. 71 indexed citations
19.
Zhang, Ronghe, et al.. (2006). Alterations in Gene Expression in Rat Skin Exposed to56Fe Ions and Dietary Vitamin A Acetate. Radiation Research. 165(5). 570–581. 14 indexed citations
20.
Li, Jingxia, Haobin Chen, Moon‐shong Tang, et al.. (2004). PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. The Journal of Cell Biology. 165(1). 77–86. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chenghui Ren Breakdown of academic impact, for papers by Monica D. Nye Breakdown of academic impact, for papers by Fei Luo Breakdown of academic impact, for papers by Hengning Ke Breakdown of academic impact, for papers by Cynthia C. Jose Breakdown of academic impact, for papers by Tiffany A. Katz Breakdown of academic impact, for papers by Shirin Hafezi Breakdown of academic impact, for papers by Nasser Pouladi Breakdown of academic impact, for papers by Susanne Haas Breakdown of academic impact, for papers by Daniel Mailo
Rankless by CCL
2026